Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-21 pm EDT 		5-day change 1st Jan Change
1.4 USD -2.10% Intraday chart for Inhibikase Therapeutics, Inc. -0.71% +10.24%
Jun. 17 Inhibikase Therapeutics Completes Enrollment of the Phase 2 ?201? Trial Evaluating Risvodetinib in Untreated Parkinson?s Disease CI
Jun. 05 Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
INHIBIKASE THERAPEUTICS, INC.
Other Biotechnology & Medical Research
-2.10%-0.71%+10.24%-61.00% - 10.32M
Neutral
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. Comparison Chart